Differential Expression of microRNAs in Thymic Epithelial Cells from Trypanosoma cruzi Acutely Infected Mice: Putative Role in Thymic Atrophy by Leandra Linhares-Lacerda et al.
ORIGINAL RESEARCH




University of São Paulo, Brazil
Reviewed by:
Muriel Moser,
Université Libre de Bruxelles, Belgium
Bin Li,
Chinese Academy of Sciences, China
*Correspondence:
Leandra Linhares-Lacerda,
Laboratory on Thymus Research,
Oswaldo Cruz Institute, Oswaldo Cruz
Foundation, Av. Brasil, No 4365.
Pavilhão 26/Sala:
506-FIOCRUZ-Manguinhos,




Cintia Cristina Palu have contributed
equally to this work.
Specialty section:
This article was submitted to
Immunological Tolerance,
a section of the journal
Frontiers in Immunology
Received: 13 May 2015
Accepted: 06 August 2015
Published: 21 August 2015
Citation:
Linhares-Lacerda L, Palu CC,
Ribeiro-Alves M, Paredes BD,
Morrot A, Garcia-Silva MR, Cayota A
and Savino W (2015) Differential
expression of microRNAs in thymic
epithelial cells from Trypanosoma
cruzi acutely infected mice: putative
role in thymic atrophy.
Front. Immunol. 6:428.
doi: 10.3389/fimmu.2015.00428
Differential expression of microRNAs
in thymic epithelial cells from
Trypanosoma cruzi acutely infected
mice: putative role in thymic atrophy
Leandra Linhares-Lacerda1*†, Cintia Cristina Palu1†, Marcelo Ribeiro-Alves2,
Bruno Diaz Paredes3, Alexandre Morrot4, Maria Rosa Garcia-Silva5, Alfonso Cayota5 and
Wilson Savino1
1 Laboratory on Thymus Research, Institute Oswaldo Cruz, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 2 HIV/AIDS
Clinical Research Center, National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil, 3 The
National Institute of Science and Technology for Structural Biology and Bioimaging, Federal University of Rio de Janeiro, Rio de
Janeiro, Brazil, 4 Department of Immunology, Microbiology Institute, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,
5 Functional Genomics Unit, Institut Pasteur de Montevideo, Montevideo, Uruguay
A common feature seen in acute infections is a severe atrophy of the thymus. This occurs
in the murine model of acute Chagas disease. Moreover, in thymuses from Trypanosoma
cruzi acutely infectedmice, thymocytes exhibit an increase in the density of fibronectin and
laminin integrin-type receptors, with an increase in migratory response ex vivo. Thymic
epithelial cells (TEC) play a major role in the intrathymic T cell differentiation. To date,
the consequences of molecular changes promoted by parasite infection upon thymus
have not been elucidated. Considering the importance of microRNA for gene expression
regulation, 85 microRNAs (mRNAs) were analyzed in TEC from T. cruzi acutely infected
mice. The infection significantly modulated 29 miRNAs and modulation of 9 was also
dependent whether TEC sorted out from the thymus exhibited cortical or medullary
phenotype. In silico analysis revealed that these miRNAs may control target mRNAs
known to be responsible for chemotaxis, cell adhesion, and cell death. Considering that
we sorted TEC in the initial phase of thymocyte loss, it is conceivable that changes in TEC
miRNA expression profile are functionally related to thymic atrophy, providing new clues
to better understanding the mechanisms of the thymic involution seen in experimental
Chagas disease.
Keywords: Chagas disease, thymus atrophy, thymic epithelial cell, microRNA, thymocyte migration
Introduction
The thymus is a common target organ in infectious diseases (1). This primary lymphoid organ
is responsible for bone marrow-derived T cell precursors differentiation from the most imma-
ture CD4 CD8  phenotype to CD4+CD8+ and finally in CD4+CD8  or CD4 CD8+ T cells
that will colonize secondary lymphoid organs (2). These maturation steps occur while these
cells migrate through the thymic lobules and interact with microenvironmental cells, particularly
Abbreviations: AIRE, autoimmune regulator; ECM, extracellular matrix; pGE, promiscuous gene expression; TEC, thymic
epithelial cells.
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thymic epithelial cells (TEC) (3). TEC guide the T cell maturation
by production of cytokines, chemokines, hormones, adhesion
molecules, extracellularmatrix (ECM)proteins, and by expression
of different ligands, like Notch, as well as self-peptides in the con-
text ofmajor histocompatibility complex (MHC). The self-peptide
presentation determines T cell fate through positive and negative
selection events, where immature lymphocytes expressing ran-
domly rearranged T-cell receptor will be selected based on their
differential ability to recognize the complex peptide/MHC (4–7).
All intrathymic T cell maturation steps generate lineage commit-
ted and self-tolerant T cells capable to perform immunological
functions in the periphery. However, the intrathymic homeosta-
sis is disrupted in numerous acute infectious diseases leading
to thymus atrophy (1). The transient thymic involution can be
caused not only by infection but also due to other forms of stress
and also occurs progressively with aging in a permanent way,
as reviewed elsewhere (8). The biological advantages of thymic
involution are currently uncertain, although there is evidence
that thymic alterations triggered by Trypanosoma cruzi infec-
tion explain part of the clinical outcomes observed in chagasic
patients (8, 9).
Chagas disease acute phase is characterized by apparent cir-
culating parasites and tissue parasitism with intense production
of reactive nitrogen intermediates, such as nitric oxide (NO) and
cytokine release: interleukin (IL)-12, interferon (IFN) γ, tumor
necrosis factor (TNF) α by macrophages, natural killer (NK)
and T cells, with an activation pattern characterized by a polar-
ized type-I response (10). However, there is also the production
of anti-inflammatory cytokines, such as IL-4, IL-10, and trans-
forming growth factor (TGF) β, that together with glucocorti-
coids (GC) control the immune response (11). Such response
plays a role in containing parasite replication in acute phase
and influences disease severity during the chronic phase of the
infection (12).
Trypanosoma cruzi acute infection in mice causes a severe
thymic atrophy, which becomes noticeable during early infec-
tion and increases progressively in parallel with parasitemia
and pro-inflammatory cytokine levels (10). Additionally, even
though T. cruzi infected cells can be found in the thymus (13,
14), current evidence demonstrates that the organ is mostly
affected by systemic effects of the infection (15, 16). Actually,
the parasite-associated response goes beyond the immune sys-
tem with the activation of hypothalamus–pituitary–adrenal axis,
resulting in hormonal imbalance that affects intrathymic home-
ostasis (9, 17). The neuroendocrineimmnune imbalance promotes
a massive depletion of immature CD4+CD8+ T cells, which
together with the export of these thymocytes to periphery, trigger
thymic atrophy (16). Those intrathymic migratory abnormalities
somehow benefit the immature thymocytes to bypass negative
selection events, which reinforces the role of TEC in thymic
atrophy, since in acutely T. cruzi infection, TEC enhanced the
deposition of ECM, such as laminin and fibronectin, as well as
chemokines, favoring developing T-cell migration (18–21). Nev-
ertheless, the mechanism by which TEC mediate thymic invo-
lution remains poorly understood. microRNAs (miRNAs) can
be envisioned as one group of candidates. miRNAs are small
non-coding RNA molecules that suppress gene expression at
the post-transcriptional level, and are fine-tuning regulators of
diverse biological processes (22, 23).
In these respect, it has been shown that induction of thymic
involution through poli(I:C) treatment is under tight control of
miRNA-29a, which regulates interferon-α receptor (IFNαR1) in
TEC, resulting in a very sensitive mechanism of thymic atrophy
(24). In fact, TEC are programed to reduce functionality and
suspend thymopoiesis in response to IFN-α (8). Recent studies
suggest that miRNAs are important factors in the maintenance
of tissue-restricted antigens expression in medullary TEC (7).
Taken together, a molecular regulation of infection-associated
thymic involution prompted us to analyze the expression of
miRNAs in cortical and medullary TEC from T. cruzi acutely
infected mice.
Materials and Methods
Experimental Acute Trypanosoma cruzi Infection
Male C57BL/6 mice were provided by the Oswaldo Cruz Foun-
dation animal facilities (Rio de Janeiro, Brazil). Five weeks
old mice were infected by intraperitoneal injection of 1 103
T. cruzi (Y strain) trypomastigotes. The parasites were main-
tained by serial passages in male mice from the same strain,
harvested after 7 days post-infection (dpi) through cardiac punc-
ture. The collected blood was harvested in vials containing 200μl
of sodium citrate, centrifuged (1,200 rpm) for 10min, later the
plasma was collected after incubating for 30min in 37°C and
centrifuged (3,000 rpm) during 10min. The pellet containing
parasites was resuspended and the trypomastigote concentration
was estimated using Neubauer chamber in order to prepare a
solution with 5,000 parasites/ml was prepared. Each mouse was
infected with 200μl of this solution. The uninfected (control)
mice were kept under the same conditions through the infection
progress.
Parasitemia was estimated for all infected animals by direct
microscopic observation of 5ml blood obtained from the tip
of the tail. Initially, 10 mice were infected and the parasitemia
was done on the following 6–18 days, once the parasitemia pick
was determined, the estimation of circulating trypomastigoteswas
done solely 8 dpi to confirm that the infection was well succeeded.
All experiments and animal handling were conducted accord-
ing to the rules prescribed by the official ethics committee for
animal research of the Oswaldo Cruz Foundation.
Analysis of Thymocyte Subpopulations
Sixteen mice were infected as described above and their thymuses
were harvested between 9 and 12 dpi, 4 thymuses plus 1 from
control mouse per day (total of 16 acutely Chagas infected mice
and 4 controls). The organs were individually squeezed in PBS
containing fetal calf serum10% (Gibco). For analysis of thymocyte
subsets, cells were resuspended in mouse serum during 15min
and incubated with specific monoclonal antibodies for 30min
at 4°C in the dark (anti-CD4/APC, anti-CD8/FITC, from BD
Pharmingen), followed bywashing and analysis on flow cytometer
FACS Canto II (BD Biosciences) and using the FACS Diva v6.1.3
software. In order to determine specific fluorescence intensity, the
background staining values obtained with fluorochrome-matched
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IgG isotype controls were subtracted. Thymocytes from 12 to
14 dpi also underwent these procedures, four infected and two
control mice each time, in order to confirm that the infection led
to thymic atrophy.
The variation of CD4+CD8+ cells due to infection progression
was tested by one-way ANOVA, followed by the Tukey’s honestly
significant difference (HSD) post hoc test.
Thymic Epithelial Cell Sorting
Five thymuses from 12 days post-infection mice or control mice
were used for TEC isolation procedure, which was performed as
described (25) with some modifications. Briefly, thymuses were
minced and transferred to round-bottom tubes and agitated in
50ml of RPMI-1640 for 30min for initial thymocytes release,
after which the remaining tissue was digested with two sequential
changes of collagenase/DNAse I solution [50mg/ml collagenase
D (Roche), 1mg/ml DNAse I (Roche) in RPMI medium] at
37°C for 15min each, followed by one collagenase/dispase/DNAse
I [50mg/ml collagenase/dispase (Roche), 1mg/ml DNAse I in
RPMI medium] at 37°C for 30min under continuous stirring.
Cells were then centrifuged, pooled, and resuspended in cold
EDTA/FACS buffer (5mM EDTA in PBS with 2% FCS and 0.02%
NaN3), filtered through 100μm mesh and counted in Neubauer
chamber. Then, anti-CD4 and anti-CD8 Dynabeads (Invitrogen)
were added at 500μl/108 cells according to the manufacturer’s
protocols. Remaining cells were then pooled and recovered by
centrifugation, washed in EDTA/FACS buffer and 5 106 cells
dispensed into the wells of a 96-well round-bottomed plate for
staining. We incubated the biotinylated anti-mouse I-A[b] pri-
mary antibody (BD Pharmingen) for 30min at 4°C, followed
by a wash in 100μl of EDTA/FACS buffer, after we added the
secondary APC-Cy7-conjugated streptavidin and the conjugates:
FITC-conjugated UEA-1 lectin (Vector), PerCP conjugated anti-
CD45 antibody (clone 30-F11), PE-conjugated anti-Ly51 anti-
body (clone 6C3), APC-conjugated CD326 antibody (EpCAM,
clone D8.8), all from BD Pharmingen. Cells isolated and stained
as outlined above were resuspended in EDTA/FACS buffer at
1 106 cells/ml. Sorting was performed in a FACS Aria II cell
sorter (BD Biosciences). Samples were collected in 50% (v/v) fetal
calf serum in RPMI, recovered by centrifugation, counted and
analyzed for purity.
RNA Extraction
The sorted population was submitted to RNA extraction using
miRNEasy (Qiagen), which allows the isolation of small RNA
(withmiRNAs) andmessenger RNA (mRNA) separately. To allow
normalization of sample-to-sample variation in miRNA isola-
tion, cDNA synthesis and real-time PCR, synthetic Caenorhab-
ditis elegans miRNA cel-miR-39 (Qiagen) was added as 5μl
of 25 pmol solution to each denatured sample (i.e., after com-
bining the sample with Qiazol) and quantified in all samples
with an average recovery ranging from 26 to 36 in crossing
point (CP) (Figure S1 in Supplementary Material). After this,
we proceeded with other extraction steps following the manu-
facturer’s instructions. The quantity and quality of RNA were
assessed on NanoDrop ND-1000 Spectrophotometer (Thermo
Scientific) and 2100 Bioanalyzer (Agilent Technologies) using
the small RNA LabChip kit and RNA 6000 nano kit (Agilent
Technologies).
AIRE Gene Expression by Quantitative
Polymerase Chain Reaction
Gene expression for AIRE (Autoimmune regulator gene) and
reference genes were carried out using 30 ng of total RNA with
SuperScript III kit (Invitrogen) for reverse transcription reaction
and FAST SYBR Green Master Mix (Applied Biosystems) and the
following primers: AIRE (F-GGCAGGTGGGGATGGAATGC
andR-TTCAGACGGAGCGTCTCCTGG),HPRT (F-TCCCAGC
GTCGTGATTAGCGATG and R-GGCCACAATGTGATGGCC
TCCC) and RPL13 (F-CCAAGCAGGTACTTCTGGGCCGGAA
and R-CAGTGCGCCAGAAAATGCGGC) for quantitative poly-
merase chain reaction (qPCR) on Step ONE Plus Fast Real Time
PCR System (Applied Biosystems).
miRNA Expression Profiling
microRNA (30 ng) was submitted to reverse transcription by
poly-A-tailing using RT2 miRNA First Strand Kit (Qiagen) as
described in the manufacturer’s protocol. We then performed
miRNA expression profiling using a custom PCR array plate
with 85 miRNA (Qiagen) and RT2 SYBR Green qPCRMastermix
(Qiagen) on Step ONE Plus Fast Real Time PCR System (Applied
Biosystems). For normalization, we used all five references
cel-miR-39, snoRNA142, snoRNA251, Rnu6, and snoRNA20
(Figure S1 in Supplementary Material) after gene expression sta-
bility analysis (26).
Quantitative PCR Analysis
The fluorescence accumulation data of real-time RT-PCR reac-
tions of each sample were used to fit four parameters sigmoid
curves to represent each amplification curve using the library
qPCR (27) for theR statistical package version 3.1.2 (28). The cycle
of quantification was determined for each amplification, by the
maximum of the second derivative of the fitted sigmoid curve.
The efficiency of each amplification reaction was calculated as
the ratio between the fluorescence of the cycle of quantification
and the fluorescence of the cycle immediately preceding that.
The estimated efficiency of each miRNA or gene was obtained
by the mean of the efficiencies calculated for each amplification
reaction of that precise miRNA or gene. microRNA normaliza-
tion among the different amplified samples was achieved by the
calculation of normalization factors given by the geometric mean
of the expression value of all expressed miRNAs in a given sample
(26). AIRE normalization was done by the geometric mean of
the expression value of HPRT and RPL13 reference genes. The
comparisons of means of normalized miRNA or AIRE expression
values between groups were performed by a non-parametric one-
way ANOVA with 1,000 unrestricted permutations, followed by
post hoc pair-wise comparisons with Bonferroni adjustment by a
non-parametric t-test also with 1,000 permutations (29). Addi-
tionally, false-positive ratios (FDR) were estimated to adjust for
multiple comparisons (30). Results were represented in graphs
displaying the expression levels mean SE. Two-tailed levels of
significance 0.01, 0.05, and 0.1 were considered as “highly sig-
nificant,” “significant,” and “suggestive,” respectively.
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Bioinformatics-Based Enrichment Analysis of
miRNA Targets
To predict miRNA targets, we identified putative target genes
based on predictions from five online softwares: miRanda1,
Microcosm Target2,miRNAMap3,miRTarBase4, and Target Scan5.
Any gene was considered a putative target if it was predicted in at
least three out of the five predicting software. We then performed
a gene set enrichment analysis (GSEA) with putative target genes.
A gene set was defined as all putative target genes that share the
same ontology based on the gene ontology (GO) database (31).
The over representation was assessed with a statistical score based
on a hypergeometric test with p-values 0.001. The Rgraphviz
package6 was used to illustrate the relationship between putative
targets, miRNAs and biological processes, and in calculations
of the k-core structures of the input networks using the degree
as centrality measure. Graphs follow virtual physical models
with low energy configuration, and only vectors containing
the maximum core membership for each vertex, equal to 11 or
greater, were displayed.
Results
Thymic Atrophy in Trypanosoma cruzi Acute
Infection
Since the interaction between thymocytes and TEC play a major
role in T-cell development, variations in TEC gene expressionmay
alter the thymic environment with consequences on thymocyte
fate (4). Accordingly, we analyzedmiRNAprofiles variation due to
infection in the initial point of thymic atrophy to avoid secondary
effects caused by thymocyte loss or consequent microenviron-
mental modifications. We used the decay of CD4+CD8+ thymo-
cytes number to define when the thymus should be harvested.
Intraperitoneal acute infection led to a parasite load picking at
8 dpi, and characterized by the high number of metacyclic trypo-
mastigotes found circulating in the peripheral blood (Figure 1A).
During the following days a decrease of CD4+CD8+ thymocytes
was observed (Figure 1B) and later, a severe thymic atrophy with
an average loss of 80% of CD4+CD8+ thymocytes was seen on
the 14th dpi (Figure 1C). On the 12th dpi, this cell subpopulation
was significantly reduced when compared with cell counting from
control and 9–10 dpi mice (Figure 1B), preceding the thymic
atrophy, thuswe perform the following experiments using samples
at this time point of infection.
Cortical and Medullary TEC Sorting
In order to prepare pure populations of primary (freshly har-
vested) cortical and medullary TEC (respectively cTEC and
mTEC), thymuses from control and infected mice were har-
vested at 12 dpi and disaggregated by enzymatic digestion, where
most thymocytes were eliminated and TEC were enriched,








FIGURE 1 | Trypanosoma cruzi acute infection induces progressive
thymic atrophy and CD4+CD8+ thymocyte loss. Nine C57BL/6 mice
were infected with 1,000 metacyclic trypomastigotes and in the following
6–18days the parasitemia was accessed to verify the infection progression.
(A) The box plot shows the median amount of parasites per blood milliliter,
upper and lower quartiles, maximum and minimum values (whiskers)
excluding outliers (circles). Once the infection peak was identified (8 dpi), the
thymocyte subpopulation variation in the following days was studied in order
to identify when the CD4+CD8+ thymocyte loss starts. (B) The
cytofluorometric profiles of thymocytes were obtained staining with anti-CD4
and anti-CD8. Thymocytes from three or four mice were submitted to FACS
analysis on days 9–12 post-infection (dpi). The plots represent the mean
number of cells SD in each day. The described decrease on CD4+CD8+
thymocyte subpopulation due to infection progression was confirmed (ANOVA
p-value=0.0002) and the Tukey’s honestly significant difference (HSD)
post-test revealed significant differences in each dpi. (adjusted p-value
*0.05, **0.01, and ***0.001) (C) Thymocyte subpopulation percentages
data derived from the cytofluorometric profiles show that by 14 dpi the thymic
atrophy is reached. Each bar represents thymocytes from a single mouse.
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with Ulex europaeus Lectin 1 (UEA1) and antibodies against
CD45, MHC-II, EpCAM, and Ly51 and sorted (Figures 2A–D).
Post-sort analysis revealed more than 98% purity for corti-
cal TEC (CD45 MHCII+EpCAM+Ly51+UEA1 ) and 95% for
medullary TEC (CD45 MHCII+EpCAM+Ly51 UEA1+) pop-
ulations (Figures 2E–F, respectively).
To further validate the purity of sorted cell populations, we
analyzed AIRE gene expression (Figure 2G), typical of medullary
TEC. As expected, the AIRE expression was higher in medullary
TEC populations, with the subpopulation classified as cTEC
exhibiting average expression close to zero. In fact, the data from
three independent sorting pointed out that, on average, AIRE
relative expression on mTEC is 29.45 times higher than in cTEC.
There was no significant difference between samples from control
and infected condition (p= 0.31), indicating that the infection by
itself does not affect AIRE levels, although we have detected a
significant interaction effect. This result suggests that the differ-
ence on AIRE expression due to TEC phenotype varies if there
is infection (p= 0.04). Actually, the detected levels in TEC from
infected animals where 13.45 times lower than samples from
control mice.
Changes in TEC-Derived microRNA Profiling in
Response to Experimental Chagas Disease
We analyzed herein 85 miRNAs in order to approach putative
molecular alterations in TEC following response to T. cruzi acute
infection, and that might be related to the previously reported
thymic atrophy and abnormal scape of immature thymocyte
(20, 21, 32, 33). We found that 29 out of the 85 miRNAs were
significantly differently expressed between TEC from infected
and normal mice (adjusted p 0.05), all were up-regulated
(Figure 3) whereas differences in further 13 miRNAs were sug-
gestive (Figure S3 in Supplementary Material).
We also detected significant interaction effect for 9 miRNAs
(adjusted p-value 0.05 FDR corrected), where the response to
the infection differed according to the TEC phenotype (Figure 3;
Figure S2 in SupplementaryMaterial), indicating that the increase
rate of miRNA expression is higher in cortical TEC.
Additionally, seven miRNAs exhibited a consistent pattern of
no amplification in TEC from infected animals (miR-144, miR-
208b, miR-291b-3p, miR-295, miR-302a, miR-488, and miR-654-
3p, Figure S4 in Supplementary Material). These miRNA can
target genes involved with TGF-β signaling pathway (Palu et al.,
unpublished data).
Trypanosoma cruzi Acute Infection Increases
Expression of miRNA known to Modulate
Important Biological Processes
More than 60% of mammalian mRNAs are regulated by miRNA,
whereas many can be targeted by more than one miRNA. Con-
versely, a single miRNA can have more than one target (34).
Here, we identified miRNAs modulated in TEC due to T. cruzi
infection, based on differential expression between infected and
control mice.
To approach the putative roles of these miRNAs, we identified
potential targets using available algorithms. Yet, these algorithms
usually predict hundreds of potential target genes for a single
miRNA and often generate false-positive candidates. In order to
reduce such a high number of theoretical targets, and to make
a more reliable prediction, we applied five different algorithms,
and considered as potential targets only those genes predicted by
at least three of these algorithms. The results from miRNAs pre-
dicted targets analysis were then combined with GO-term enrich-
ment analysis to identified biological processes over represented
among the list of target genes, so that to identifymiRNAassociated
biological functions. Significant enrichment of predicted targets
revealed cell adhesion, cell migration, and cell death among others
biological processes (Figure 4).
Potential Network among miRNAs and
Corresponding Predicted Targets
Given the lack of data regarding TEC molecular pathways during
infection, we evaluated in silico potential interaction network
between 29 differentially expressed miRNAs and the predicted
targets related to cell death, cell migration, and cell adhesion
(Table S1 in Supplementary Material). The complexity of the
relationships is shown in Figure 5, where the elements shown
were selected based on having the minimum of 11 relations.
All 17 miRNAs have at least one putative target related to the
negative regulation of extrinsic apoptotic signaling (GO:2001237),
a process that was also related to 12 out of the 58 illustrated genes.
Nevertheless, among the genes involved in cell death, only Bcl2l11
was exclusively related to positive regulation of cell death. These
miRNAs could be targeting Serpine1, Tgfbr1, Vegfa, Igf1, Hgf,
Snai2, Rffl, Map2k5, Itgav, and Sgms1 mRNAs, which are related
to inhibition of apoptotic externals signals.
Many putative targets (32 out of 56) were related to cell migra-
tion, whereas 18 were associated to chemotaxis. More interest-
ing, the presence of 21 targets associated with positive regula-
tion of cell migration suggests that miRNAs could be inhibiting
molecules that promote migration. Among the 17 targets associ-
ated to adhesion, 8 are known to be involved in positive regulation
(GO:0045785) and cell-cell adhesion (GO:0016337). The increase
in miRNA targeting genes that favor adhesion may explain some
of the described alterations in T. cruzi acutely infected mice.
Discussion
The mechanisms by which TEC regulate thymic atrophy appear
to be under the tight control of miRNAs (24). Here, we analyzed
the miRNA expression in cortical and medullary TEC from T.
cruzi acutely infectedmice. Our results provide novel insights into
the molecular regulation of TEC-associated thymic involution
secondary to infection, using the experimental model of acute
Chagas disease.
It has been previously shown that thymic involution, reduc-
tion on T cell output, increased susceptibility to autoimmune
disease and loss of TEC numbers are associated with ablation
of mature miRNAs (7). Although those are events similar to the
ones observed in infected mice, it is noteworthy that the infection
induced an upregulation of differentially expressed miRNAs in
both cTEC andmTEC subsets, whereas in some cases the increase
in expression was significantly higher only in cTEC, suggesting
that the T. cruzi infection triggers different responses according
to TEC phenotype.
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FIGURE 2 | Ex vivo thymic epithelial cell sorting. Five replicates of
thymic cell pools from control and infected mice were sorted using flow
cytometry in order to isolate TEC. (A) Initially, CD45  cells were selected
based on size, (B) from this population, MHC-II positive cells were isolated
after EpCAM confirmation (C). (D) Then, according to UEA-1 and Ly51
surface markers, these cells were distinguished between cortical TEC (cTEC,
Ly51+, and UEA , orange) and medullary TEC (mTEC, Ly51 , and UEA+,
blue) phenotypes. Post-sorting analysis revealed 98% purity in cTEC
(E) while 95% purity in mTEC (F). (G) After miRNA isolation, the remaining
mRNA from three experimental pools allowed us to analyze AIRE gene
expression, confirming if the sorted cells matched the correct expected TEC
profile. The bar plot represents the average expression in each condition. “a”
indicates the magnitude of the expression ratio (log 2) due to TEC
phenotype, whereas a positive value shows a higher expression in mTEC.
“ab” indicates the expression ratio magnitude (in log 2) as consequence of
the combination between infection and cell type, whereas a negative value
shows that the AIRE expression in infected mTEC is lower than in control
mTEC.
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FIGURE 3 |miRNA relative expression in thymic epithelial cells from
control and infected mice. The miRNA expression of 85 miRNAs was
analyzed for each sorted TEC population, in five replicates, with samples from
control (dark blue) and infected (light blue) mice being paired. We present the
29 miRNAs that were significant (adjusted p-value 0.05) differentially
expressed due to infection and the samples clustered according to expression
profile similarity. Three groups of samples were identified based on their
expression profile, as illustrated by the dendrogram.
Among miRNAs significantly modulated due infection, miR-
27a and miR-27b, also exhibited dependence whether TEC sorted
out from the thymus exhibited cortical or medullary phenotype.
Mature miR-27a and miR-27b differ from each other by just one
nucleotide and are transcribed from paralog clusters, the inter-
genic miR-23a~27a~24 cluster (localized in chromosome 9q22)
and the intronic miR-23b~27b~24 cluster (localized in chromo-
some 19p13) (35, 36). Yet, there is limited information regarding
the functions of this cluster in infectious diseases. Herein, we
found an upregulation of the miR-23b~27b~24 cluster, thus at
variance with the findings observed in primary macrophages,
which exhibit rapid decrease miR-27a and miR-27b expression
upon murine cytomegalovirus infection (37). Nevertheless, the
Cryptosporidium parvum infection, a protozoan parasite that
infects the gastrointestinal epithelium, causes miR-27b upregu-
lation that suppresses KH-type splicing regulatory protein and
contributed to epithelial production of NO, helping the epithelial
antimicrobial defense (38). In T. cruzi infection, the serum levels
of NO increase both in mice and humans (9, 39), and high intrac-
ardiac contents of NO synthase and NO metabolites have been
detected (40). Interestingly, T. cruzi can infect TEC and, although
only small fractions of TEC are invaded (13, 14), the presence of
the parasite may trigger NO production.
Regarding the 23b~27b~24 cluster upregulation, miR-24 can
be highlighted. It is known that mRNA-target for a particular
miRNA depends of cell context and this is the case of miR-24,
which has been described in apoptosis and cell survival (41–
44). In cardiomyocytes, miR-24 directly targets the proapoptotic
protein Bim and inhibits apoptosis. Moreover, in vivo delivery
after myocardial infarction suppressed cardiac cell death and res-
cued cardiac dysfunction (42). Yet, miR-24 function is complex
since it enhanced survival in myeloid and B cell lines, as well
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FIGURE 4 | Putative enriched biological processes modulated by TEC
miRNA following Trypanosoma cruzi infection. The putative mRNA targets
for the 29 miRNAs that were differentially expressed due to infection are
consistently involved in a long list of biological processes. Here, we show the
most relevant processes in the context of cell death (blue), adhesion (green),
and migration (red). The full length of the bars represent the total putative target
mRNAs known to be involved in this process, in opposition to the colored bar
inside, that represents the expected mRNA number. On the right side of each
bar, there is the adjusted p-value indicating that the enrichment of those events
is not by chance.
as primary hematopoietic cells (44). Importantly, it has been
shown that miR-24 expression differed in age-related thymic
involution. When comparing young versus aged TEC (a mix of
cTEC and mTEC) a decrease in miR-148b, miR-19b, miR-24,
and miR-322 expression was seen in aging (45). Herein, using
T. cruzi-induced thymic atrophy, we showed an upregulation of
these miRNAs in TEC. Both infection and aging-induced thymic
involution are due to multifactorial events; in the aging case,
we can highlight the sex hormone dependence and the increase
in adipose tissue, whereas in infection, the immune inflamma-
tory response and stress-related hormones are undoubtedly rel-
evant (16, 46, 47). Nevertheless, it has yet to be established the
tuned regulation of this miRNA in the various thymic atrophy
induced situations.
It is important to take into account that changes in miRNA
profile seen here are in consequence of the thymic stress brought
out by the infection with activation of the immune system and
the hypothalamus–pituitary–adrenal axis. This stress results in
hormonal imbalance (high levels of GC) that affects intrathymic
homeostasis promoting thymic atrophy by a massive depletion of
immature CD4+CD8+ T cells and the export of immature thy-
mocytes to periphery (9, 16, 17). Under stress conditions, miRNA
can act as restorer to homeostasis or as an enforcer of new gene
expression program so that to adapt to the new condition (34). An
example is the regulatory action exerted by miR-10a and miR-182
upon Th1- or Th2-associated T regulatory cells, respectively,
where CD4+Foxp3+ cells orchestrate distinct miRNA pathways
in response to local environmental factors (48). Furthermore,
miR-10a expression is stimulated by TGF-β, making it a good
example of how environmental factors coordinate distinctmiRNA
pathways and regulates cell fate. In fact, TGF-β seems to be a
molecular node of the infection since the gene encoding its recep-
tor appears in the middle of our microRNA network (Figure 5),
where the gene for TGF-β2 is also present. TGF-β is able to reg-
ulate CD4 CD8  development through direct interaction with
thymocytes but also by binding to TEC surface (49). Although, it is
unclear if the increasedmiR-10a in TEC from infectedmice is part
of a host response due TGF-β enhancement or ifmiR-10a is a fine-
tuning factor in TEC, our results suggest that TGF-β signaling is
a key pathway in the thymic involution process. More studies will
be necessary to define TGF-β role in TEC, but it has been already
shown that the inhibition of this pathway decelerates the process
of age-related thymic involution (50), therefore suggesting a
common pathway between thymic involution due to senescence
and infection.
Interestingly, GC also regulated miRNAs (51, 52). The sys-
temic stress induced by dexamethasone intraperitoneal injection,
a synthetic GC causes a significant loss of the CD4+CD8+
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FIGURE 5 | Theoretical relationship among the most recurrent
miRNA, mRNA, and biological processes. The network of the 29
differentially expressed miRNAs and their targets is very complex. To
illustrate this network, only molecules or processes related with at least
11 elements are shown. There are 17 miR differentially expressed due to
infection (cyan) and their 58 putative targets (yellow), plus 18 biological
processes related to it. Biological processes are identified by gene
ontology (GO) tags, where blue represents cell death, red are cell
adhesion, and green cell migration. The relationships are illustrated by the
arrows.
thymocytes within 24 h and a reduction in miR-17-92 cluster
(miR-17, miR-20a, miR-20b, and miR-106a) in whole thymus
samples (52). Although we were also studying miRNA expression
in a condition where there is CD4+CD8+ cell loss, in TEC we
observed an upregulation of miR-20b and a suggestive increase
in miR-20a expression, suggesting that intrathymic regulation of
miR-20b is cell type specific.
Glucocorticoids can also reduced the protein expression of
Drosha’s co-factor DGCR8/Pasha and Dicer, two indispens-
able enzymes for miRNA bioprocessing pathway in thymo-
cytes (51). Moreover, Dicer- and DGCR8-deficient mice are
incapable to sustain proper thymic architecture and promote
thymocyte development, with a severe loss of TEC, demon-
strating the miRNA role in TEC maintenance and function
(32, 33). In fact, in mice where TEC do not produce miRNA
due conditionally inactivate Dgcr8 gene, there is a specific
loss of mature mTEChi and AIRE+ subsets that induce a
breakdown in thymic central tolerance with the presence of
autoantibodies or development of spontaneous autoimmunity
(33). On the other hand, AIRE knockdown results in mod-
ulation of different miRNAs (53, 54), with upregulation of
miR-20b, miR-191, and miR-411 (54), which is consistent with
our observation. In our study, there was donwregulation of
AIRE expression due infection, concomitant with upregulation of
those miRNAs.
Abnormally release of potential autoreactive T cells from
the thymus occurs in patients with severe clinical form of
Chronic Chagas disease and also in mouse experimental model
(19). Intriguingly, despite the thymic escape of T cells bear-
ing “forbidden” T cell receptor that should be deleted by
negative selection (21), some evidence points to normal promis-
cuous gene expression in infected thymuses suggesting that
negative selection can induce tolerance. Indeed, the escape
of CD4+CD8+ T cells to the periphery seems to be more
related with a higher fibronectin-driven migration than defects
in negative selection (18, 20, 21). Considering that TEC play
a role in thymocyte migration and that we defined enhanced
intrathymic fibronectin and laminin deposition in T. cruzi
acutely infected mice (1), we performed biological processes
GO-term enrichment analysis and evaluated in silico poten-
tial interaction network among the 29 differentially expressed
miRNAs and their predicted targets. This network analysis
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predicted cell adhesion, regulation of cell–matrix adhesion, cell
migration, chemotaxis, regulation of programed cell death, and
apoptotic processes to be altered as a consequence ofT. cruzi acute
infection. Taking together, these data point out miRNA as can-
didates to orchestrate thymic atrophy from the TEC perspective,
since the alteration herein studied precedes the involution.
The intrathymic T cell migration is a multivectorial process
where each individual vector represents a given molecular inter-
action, as, for example, those interactions mediated by ECM.
Accordingly, changes in the ECM contents should result in mod-
ulation of thymocyte migration (4, 20). Although there are studies
in cancer (55), there is a lack of information concerning the role
miRNAs in regulating ECM molecules in the thymus, and more
particularly in TEC. We found correlations indicating putative
intrathymic functions for some miRNAs, such as miR-183 that
direct regulates integrin β1 expression (56), miR-143, suppress-
ing fibronectin directly (57), miR-218 controlling focal adhe-
sion kinase (58), and miR-203 increasing metalloproteinase-1
expression (59).
Overall, in this study, we show differentially expressed miR-
NAs in TEC from T. cruzi acutely infected mice, highlighting
miRNAs as possible mediators of thymic atrophy. To our knowl-
edge, this is the first study to show miRNA expression in TEC
from infected mice. Further studies are needed to define the
targets and dissect the role of TEC miRNAs in the context of
infection.
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Figure S1 | Selection of multiple internal control reference for normaliza-
tion. (A) Calculation of average expression stability values of five different internal
control reference, including one spike-in (cel-miR-39), using geNorm (23). The
geometric mean of five small RNAs (Rnu6, cel-miR-39, snoRNA251, snoRNA
142, and snoRNA 202) was used for normalization. Crossing point mean of the
samples shows the level of expression for (B) cel-miR-39 (C), snoRNA 142, and
(D) snoRNA202.
Figure S2 | Significant differentially expressed miRNA in thymic epithelial
cells from control and infected mice separated by TEC phenotype. The
miRNA expression of 85miRNAswere analyzed for each sorted TEC subpopulation,
in five replicates, where samples from control, cortical TEC (orange) and medullary
TEC (dark blue) and infected, cortical infected TEC (yellow) and medullary infected
TEC (light blue). We present the 29 miRNAs that were significantly differentially
expressed (adjusted p-value 0.05) due to infection.
Figure S3 | Suggestive differentially expressed miRNA in thymic epithelial
cells from control and infected mice separated by TEC phenotype. The
expression of 85 miRNAs was analyzed for each sorted TEC subpopulation, in
five replicates, where samples from control, cortical TEC (orange) and medullary
TEC (dark blue) and infected, cortical (yellow) and medullary TEC (light blue) are
showed. We present the 13 miRNAs that were suggestive significance (adjusted
p-value 0.1) differentially expressed due to infection.
Figure S4 | miRNAs with a consistent pattern of no amplification in TEC
from infected animals. The miRNA expression of 85 miRNAs was analyzed for
each sorted TEC subpopulation, in five replicates, where samples from control,
cortical TEC (orange) and medullary TEC (dark blue) and infected, cortical (yellow)
and medullary TEC (light blue) are showed. We present the seven miRNAs that
exhibited a consistent pattern of no amplification in TEC from infected animals, being
clearly detected in control samples.
Table S1 | List of microRNAs and the respective putative mRNA targets.
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